» Articles » PMID: 32080297

Ablation of Myeloid Cell MRP8 Ameliorates Nephrotoxic Serum-induced Glomerulonephritis by Affecting Macrophage Characterization Through Intraglomerular Crosstalk

Overview
Journal Sci Rep
Specialty Science
Date 2020 Feb 22
PMID 32080297
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Toll-like receptor 4 (TLR4) and one of its endogenous ligands myeloid-related protein 8 (MRP8 or S100A8), especially expressed in macrophages, play an important role in diabetic nephropathy and autoimmune disorders. However, detailed mechanisms and consequence of MRP8 expression remain unknown, partly due to embryonic lethality of MRP8 knockout mice. In this study, Myeloid lineage cell-specific MRP8 knockout mice were generated, and nephrotoxic serum-induced glomerulonephritis was developed. Mice with conditional ablation of MRP8 gene in myeloid cells exhibited less severe histological damage, proteinuria and inflammatory changes compared to control mice. Mechanism of MRP8 upregulation was investigated using cultured cells. Co-culture of macrophages with mesangial cells or mesangial cell-conditioned media, but not with proximal tubules, markedly upregulated MRP8 gene expression and inflammatory M1 phenotype in macrophages, which was attenuated in MRP8-deleted bone marrow-derived macrophages. Effects of MRP8 deletion was further studied in the context of macrophage-inducible C-type lectin (Mincle), which is critically involved in maintenance of M1 phenotype of macrophages. MRP8 ablation in myeloid cells suppressed the induction of Mincle expression on macrophages in glomerulonephritis. Thus, we propose that intraglomerular crosstalk between mesangial cells and macrophages plays a role in inflammatory changes in glomerulonephritis, and MRP8-dependent Mincle expression in macrophage may be involved in the process.

Citing Articles

Targeting Macrophages: Therapeutic Approaches in Diabetic Kidney Disease.

Lin D, Yang T, Ho C, Shih Y, Lin C, Hsu Y Int J Mol Sci. 2024; 25(8).

PMID: 38673935 PMC: 11050450. DOI: 10.3390/ijms25084350.


SOCS1 Peptidomimetic Alleviates Glomerular Inflammation in MsPGN by Inhibiting Macrophage M1 Polarization.

Zhao Y, Peng F, He J, Qu Y, Ni H, Wu L Inflammation. 2023; 46(6):2402-2414.

PMID: 37581761 DOI: 10.1007/s10753-023-01886-3.


Single Cell RNA Sequencing Identifies a Unique Inflammatory Macrophage Subset as a Druggable Target for Alleviating Acute Kidney Injury.

Yao W, Chen Y, Li Z, Ji J, You A, Jin S Adv Sci (Weinh). 2022; 9(12):e2103675.

PMID: 35112806 PMC: 9036000. DOI: 10.1002/advs.202103675.


Utilizing methylglyoxal and D-lactate in urine to evaluate saikosaponin C treatment in mice with accelerated nephrotoxic serum nephritis.

Lin C, Lee J, Lin P, Hua S, Tsai P, Chen B PLoS One. 2020; 15(10):e0241053.

PMID: 33104740 PMC: 7588094. DOI: 10.1371/journal.pone.0241053.

References
1.
Liyanage T, Ninomiya T, Jha V, Neal B, Patrice H, Okpechi I . Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015; 385(9981):1975-82. DOI: 10.1016/S0140-6736(14)61601-9. View

2.
McAdoo S, Pusey C . Anti-Glomerular Basement Membrane Disease. Clin J Am Soc Nephrol. 2017; 12(7):1162-1172. PMC: 5498345. DOI: 10.2215/CJN.01380217. View

3.
Donath M, Shoelson S . Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011; 11(2):98-107. DOI: 10.1038/nri2925. View

4.
Rosin D, Okusa M . Dangers within: DAMP responses to damage and cell death in kidney disease. J Am Soc Nephrol. 2011; 22(3):416-25. PMC: 4493973. DOI: 10.1681/ASN.2010040430. View

5.
Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, Saito Y . Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice. Diabetologia. 2012; 55(8):2256-66. DOI: 10.1007/s00125-012-2578-1. View